Back to top

Updates

  /  Updates

2020: A year of challenges and learnings The pandemic has had an undeniable impact on our daily lives, not just on LACOG's operational activities, but also on the research sites that contribute to the studies. But despite all the difficulties, we managed to adapt over the year and 2020 has been a positive one for us. We know how important the studies we carry out are for patients, and even during the pandemic, research sites have done an extraordinary job to continue treating patients safely.   We would like to thank our staff, members, partners, research centers, patients and donors for the support they have given to the LACOG mission, which is to improve cancer research and cancer patient care in Latin America.  We invite you to download LACOG’s Annual Report and discover our achievements of the last year, as well as find out more about our trajectory which seeks to have an impact on Latin American lives through cancer research. Download 2020 Annual Report

This Wednesday (16), the public was informed about the winner research of The Renata Thormann Procianoy Award, which was idealized by the Instituto Projeto Cura. The investigation, named “Randomized study addressing the use of hand-held power heater versus observation to reduce the discomfort during scalp cooling, to prevent the alopecia induced by chemotherapy”, is led by Dr. Luciana Landeiro and aims at providing overall and thermal comfort to breast cancer patients exposed to scalp cooling during their chemotherapy treatment, as an attempt to prevent the Alopecia Areata (loss of hair). The awarding ceremony was held on the 16th, as part of the 2021 Best of ASCO Annual Meeting – Brazil Edition. Winner Profile Female and born in the Northeast area of Brazil, Dr. Luciana Landeiro has defined breast cancer and gynecological tumors as her main area of investigation. The physician initiated her professional trajectory as a scholarship fellow in a Hepatology research group at the Federal University of Bahia. Years later, during her Oncology medical residence, she focused her efforts in the improvement of life quality for oncological patients. Additionally, she attended post-graduation in clinical research at the Harvard Medical School. Subsequently, during her PhD course in Clinical Oncology, at the São

The latest memo inOncology SPECIAL ISSUE summarizes a selection of abstracts of clinical interest ranging from early-stage disease to the metastatic setting. This report brings the role of adjuvant chemotherapy as well as targeted options and sequencing issues with KRAS, HER2 and ALK mutations into focus. Moreover, novel treatment approaches in the EGFR-mutated NSCLC and small-cell lung cancer, relapsed malignant mesothelioma or pretreated NSCLC are among other topics reviewed. As an additional feature, you will find expert video interviews with Alex Spira, Luis M. Montuenga & Ming Tsao on different conference highlights on our website. Another video interview with Sandip Patel will be released beginning of April. Download full report  The memo inOncology Special Issue report is produced by Springer, as a supplement of memo (the Magazine of European Medical Oncology) and sponsored by Boehringer Ingelheim and BeiGene with an unrestricted educational grant. For more information on the memo inOncology Special Issue series, and for free access to all previous editions, visit the memo-inOncology website.

In this annual multidisciplinary meeting, attended by all professionals related to breast cancer, a comprehensive review of the advances in research, diagnosis and treatment of this disease is carried out.The main objective of this event is to become the reference for all those interested in knowing in an independent, complete and critical way the advances in breast cancer. The event will take place on June 17th and 18th in a virtual format. Sign up on the website:: https://www.ragmageicam.org/ Check out the event schedule

Live Webinar, Saturday July 3th The program will offer a scientific update including original presentations from the 2021 ASCO® Annual Meeting. Renowned international speakers will select the most significant studies and provide insights on how the results may impact on clinical practice. Relevant regional speakers will complement the presentations by demonstrating the impact on clinical practice with updates to current treatment algorithms. Each section will feature a rich clinical discussion moderated by the Program chair and co-chair, complemented by opportunities for questions to be raised by the participating audience. This program has been made possible through Platinum sponsorship from MSD and Silver sponsorship from BIOMM. Register to participate

Evento em formato virtual contará com palestrantes nacionais e internacionais em sua programação para discutir os principais avanços no diagnóstico e tratamento do câncer de mama. Entre os dias 9 e 11 de março de 2021, se realizará a Conferência Brasileira de Câncer de Mama 2021, e o evento oficial licenciado Best of SABCS Brazil. Este evento é organizado pelo Latin American Cooperative Oncology Group (LACOG) e Grupo Brasileiro de Estudos em Câncer de Mama (GBECAM), instituições brasileiras dedicadas à educação e pesquisa em câncer de mama. O evento deste ano será em formato virtual e reunirá especialistas nacionais e internacionais para debater os principais avanços no diagnóstico e tratamento do câncer de mama. O primeiro dia do evento será dedicado ao Best of SABCS Brazil, no qual os participantes poderão acompanhar o que foi destaque no San Antonio Breast Cancer Symposium – realizado em dezembro de 2020, nos Estados Unidos. O SABCS é um dos mais relevantes congressos mundiais que debate pesquisa básica, translacional e clínica em câncer de mama. Os principais temas abordados no encontro serão agora apresentados e discutidos com exclusividade no Brasil. Nos outros dias do evento teremos módulos dedicados ao tratamento de doença inicial e metastática apresentando

The Genitourinary Cancers Symposium, an event organized by the ASCO focused on presenting and debating the latest research, diagnoses and treatment for genitourinary cancer, took place between February 11 and 13 in an online format. LACOG participated by presenting two studies: Bladder Cancer Registry (LACOG 1518) and the APA in Prostate Cancer (LACOG 0415). The first study, presented by Dr. Vinícius Carrera Souza, an oncologists at Instituto D’Or – Bahia, as well as an investigator and executive director for LACOG Genitourinary Group, is centered around creating a multicentric Latin American database to analyze epidemiological, clinical and pathological data; treatment; results and biological information on patients diagnosed with recurrent/metastatic transitional cell carcinoma. The second study, presented by Dr. Andrey Soares, a clinical oncologist at Hospital Israelita Albert Einstein and Centro Paulista de Oncologia and scientific director of LACOG Genitourinary Group, is being conducted with Brazilian patients and assessed several therapeutic options that present fewer adverse events and consequently gains in life quality for individuals under treatment for prostate cancer. For more information and to enroll, visit: https://meetings.asco.org/gu/attend